During early phases of tumor development, TAAs respond to initial injury with the secretion of TGFβ, IL-6, and Insulin growth factor 1 (IGF-1) which could contribute to GBM sustainment (76, 77). The gene discussed is TGFB1; the disease is glioblastoma.